Dr Reddy's US Recall of Generic Medication Due to Manufacturing Issues

Sunday, 3 November 2024, 01:38

Dr Reddy's has announced a recall of over 3.3 lakh bottles of a generic medication used to treat high calcium levels in the blood. This recall affects the US market due to CGMP deviations identified by the USFDA. The specific medication, Cinacalcet tablets, is crucial for managing hyperparathyroidism and calcium levels. Patients using this medication are advised to consult their healthcare providers.
Outlookbusiness
Dr Reddy's US Recall of Generic Medication Due to Manufacturing Issues

Details of the Recall

Dr Reddy's Laboratories is recalling over 3.3 lakh bottles of Cinacalcet tablets in the US market. The recall was prompted by manufacturing concerns, which have raised flags from the US Food and Drug Administration (FDA).

Reasons Behind the Recall

The recall is linked to issues concerning current good manufacturing practices (CGMP) deviations. These deviations refer to a failure in adherence to the essential standards for the manufacturing process.

Impact on Patients

Patients currently utilizing this medication to manage their calcium levels or hyperparathyroidism should immediately consult their healthcare professionals for alternative options.

Conclusion and Recommendations

It is crucial for patients and healthcare providers to stay informed regarding manufacturing quality and to monitor recalls. For more information, consider checking the USFDA's official website for updates on this recall.


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Subscribe to our newsletter for the most accurate and current medical news. Stay updated and deepen your understanding of medical advancements effortlessly.

Subscribe